Journal of Biological Chemistry · 2011 · 57 citations · 42 references
MedicineCardiologyGeneticsCardiovascular GeneticsClinical CardiologyMedical GeneticsChannelopathiesDilated Cardiomyopathy GeneticsInherited CardiomyopathiesCardiomyopathy GenomicsCardiomyopathy Genotype-phenotype CorrelationSarcomeric Gene VariantsTtn Truncating Variants
TNNC1, which encodes cardiac troponin C (cTnC), remains elusive as a dilated cardiomyopathy (DCM) gene. Here, we report the clinical, genetic, and functional characterization of four TNNC1 rare variants (Y5H, M103I, D145E, and I148V), all previously reported by us in association with DCM (Hershberger, R. E., Norton, N., Morales, A., Li, D., Siegfried, J. D., and Gonzalez-Quintana, J. (2010) Circ. Cardiovasc. Genet. 3, 155-161); in the previous study, two variants (Y5H and D145E) were identified in subjects who also carried MYH7 and MYBPC3 rare variants, respectively. Functional studies using the recombinant human mutant cTnC proteins reconstituted into porcine papillary skinned fibers showed decreased Ca(2+) sensitivity of force development (Y5H and M103I). Furthermore, the cTnC mutants diminished (Y5H and I148V) or abolished (M103I) the effects of PKA phosphorylation on Ca(2+) sensitivity. Only M103I decreased the troponin activation properties of the actomyosin ATPase when Ca(2+) was present. CD spectroscopic studies of apo (absence of divalent cations)-, Mg(2+)-, and Ca(2+)/Mg(2+)-bound states indicated that all of the cTnC mutants (except I148V in the Ca(2+)/Mg(2+) condition) decreased the α-helical content. These results suggest that each mutation alters the function/ability of the myofilament to bind Ca(2+) as a result of modifications in cTnC structure. One variant (D145E) that was previously reported in association with hypertrophic cardiomyopathy and that produced results in vivo in this study consistent with prior hypertrophic cardiomyopathy functional studies was found associated with the MYBPC3 P910T rare variant, likely contributing to the observed DCM phenotype. We conclude that these rare variants alter the regulation of contraction in some way, and the combined clinical, molecular, genetic, and functional data reinforce the importance of TNNC1 rare variants in the pathogenesis of DCM.
42
THE COLORIMETRIC DETERMINATION OF PHOSPHORUS
Cyrus H. Fiske, Y. Subbarow · Journal of Biological Chemistry · 1925 · 19.1K citations · Full text
Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban
Joachim P. Schmitt, Mitsuhiro Kamisago, Michio Asahi et al. · Science · 2003 · 628 citations
Medicine, Cardiology, Genetics +15
Actin Mutations in Dilated Cardiomyopathy, a Heritable Form of Heart Failure
Timothy M. Olson, Virginia V. Michels, Stephen N. Thibodeau et al. · Science · 1998 · 627 citations
Life Sciences, Cardiology, Genetics +17
S.P. Robertson, J. David Johnson, Michael J. Holroyde et al. · Journal of Biological Chemistry · 1982 · 357 citations · Full text